Life Sciences Scotland have interviewed Elasmogen’s CEO Caroline Barelle as part of their Insight series. The article can be accessed here.
discovering and developing soloMERs for the treatment of auto-immune mediated, inflammatory diseases
discovering and developing soloMERs for the treatment of auto-immune mediated, inflammatory diseases
Life Sciences Scotland have interviewed Elasmogen’s CEO Caroline Barelle as part of their Insight series. The article can be accessed here.